[HTML][HTML] The malignancy index in plasma samples as a prostate cancer biomarker
AM Serafin, A Chinhengo, P Fernandez… - Discovery …, 2018 - discoverymedicine.com
No unambiguous role of the involvement of uroplasminogen activator (uPA) and
plasminogen activator inhibitor type-1 (PAI-1) in prostate cancer has emerged, with current …
plasminogen activator inhibitor type-1 (PAI-1) in prostate cancer has emerged, with current …
[HTML][HTML] The Malignancy Index Is a Robust Predictor of Prostate Cancer
AM Serafin, A Chinhengo… - Discovery …, 2020 - discoverymedicine.com
The objective of this study was to validate the results from our published work and to test the
robustness of our unique malignancy index as a (non-invasive) predictor of prostate cancer …
robustness of our unique malignancy index as a (non-invasive) predictor of prostate cancer …